Kidney transplantation following uncontrolled donation after circulatory death

Dominic M Summers1, Gavin J Pettigrew

  • 1Department of Surgery, University of Cambridge, Cambridge, UK.

Abstract

Insights

Utilizing kidneys from uncontrolled donation after circulatory death (uDCD) donors can significantly boost kidney transplant rates. Despite some primary nonfunction, outcomes remain comparable to expanded criteria donors, offering hope for transplant waiting lists.

Area of Science:

  • Nephrology
  • Transplantation Surgery
  • Organ Donation

Background:

  • Kidney transplantation is limited by donor organ availability.
  • Donation after circulatory death (DCD) offers a potential source of organs.
  • Uncontrolled DCD (uDCD) donation presents an opportunity to expand the donor pool.

Purpose of the Study:

  • To review international outcomes of kidney transplantation from uDCD donors.
  • To assess the impact of uDCD programs on transplant waiting lists.
  • To evaluate the feasibility and results of uDCD kidney transplantation.

Main Methods:

  • Review of international data from successful uDCD kidney transplant programs.
  • Analysis of reported outcomes, including primary nonfunction rates and graft survival.
  • Estimation of the potential increase in donation rates from the uDCD pool.

Main Results:

  • Over 1000 uDCD kidney transplants reported since 2007.
  • Potential to increase donation rates by 25% through uDCD utilization.
  • Primary nonfunction incidence of 7-8%, despite careful selection and perfusion techniques.
  • 1-year graft survival comparable to expanded criteria donors (ECD).
  • 10-year graft survival reported between 72-82% in long-term follow-up studies.

Conclusions:

  • Successful implementation of uDCD kidney transplantation in France and Spain.
  • Wider adoption can substantially increase kidney availability for transplantation.
  • Acceptable transplant outcomes can be maintained with uDCD programs.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
272
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
238
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
263
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
818